Stay updated on DTX301 Clinical Trial in Late-Onset OTC Deficiency
Sign up to get notified when there's something new on the DTX301 Clinical Trial in Late-Onset OTC Deficiency page.

Latest updates to the DTX301 Clinical Trial in Late-Onset OTC Deficiency page
- CheckyesterdayChange DetectedRevision label updated from v3.4.0 to v3.4.1; this is a minor metadata change with no impact on study details or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedMinimal UI/text updates: a glossary toggle was added. Labels for QC criteria, FEAR Act data, and the page revision were updated from v3.3.4 to v3.4.0.SummaryDifference0.2%

- Check22 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed from the page.SummaryDifference0.1%

- Check51 days agoChange DetectedLocations sections were updated: new sites across the US, Canada, Spain, and the UK were added (Colorado, Massachusetts, New York, Ohio, Alberta, A Coruna, Vizcaya, London City) and the corresponding location entries were removed. The page revision label was updated to v3.3.3.SummaryDifference0.9%

- Check72 days agoChange DetectedFooter revision tag updated from v3.3.1 to v3.3.2, indicating a minor site update with no changes to study details or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check79 days agoChange DetectedThe page now displays Revision: v3.3.1, replacing the previous Revision: v3.2.0.SummaryDifference0.1%

Stay in the know with updates to DTX301 Clinical Trial in Late-Onset OTC Deficiency
Enter your email address, and we'll notify you when there's something new on the DTX301 Clinical Trial in Late-Onset OTC Deficiency page.